Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

May 02, 2023 SCLC Transformation in EGFR NSCLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on EGFR NSCLC and transformation to small cell lung cancer, a relatively new finding since the introduction of targeted therapy.
Guests are:
Dr. Shigeki Umemura
Dr. Shigeki Umemura is from the Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan. His interests include targeted therapy in lung cancer, including genomic profiling of small cell lung cancer, evaluation of tumor microenvironment and its association with response to therapy and resistance mechanisms for disease progression.
Dr. Zofia Piotrowska
Dr. Zofia Piotrowska is an assistant professor of medicine at HMS and clinical researcher and lung cancer medical oncologist at the Massachusetts General Hospital. Dr. Piotrowska has an interest in understanding and overcoming resistance to targeted therapies in lung cancer, particularly among patients with EGFR-mutant NSCLC.
38 min
April 27, 2023 Updated IASLC - ADAURA
Lung Cancer Considered hosts Dr. Narjust Flores and Dr. Stephen Liu talk with Dr. Roy Herbst about the ADAURA Trial. ADAURA introduced targeted therapy in the adjuvant setting for early-stage EGFR positive NSCLC. While we have seen targeted therapy in this space ADAURA showed DFS rates never seen before and changed the treatment of early-stage lung cancer.
41 min
April 18, 2023 IASLC - Meeting the New JTO CRR Editor in Chief
In this episode of Lung Cancer Considered, host Dr. Narjust Florez interviews Dr. Emily Stone, the new editor of JTO Clinical and Research Reports. The podcast will focus on her article “Building on a Legacy”.
33 min
April 11, 2023 IASLC - French Language Podcast
Host Dr. Alfredo Addeo, Senior Oncologist, Geneva University Hospital, in Geneva, Switzerland moderates a special French-language episode of Lung Cancer Considered focusing on managing locally advanced NSCLC. The guests for this special podcast are Dr. Cecile Le Pechoux, Radiation Oncologist at Department of Radiation Oncology Unit of Thoracic Oncology, Soft Tissue Sarcomas and Mesenchymal Tumour, and Dr. Jonathan Spicer, Associate Professor, Division of Thoracic Surgery. Director, McGill Thoracic Oncology Network, McGill University, Montreal General Hospital.
47 min
April 06, 2023 IASLC - ELCC 2023 Highlights
This episode of Lung Cancer Considered covers the recently completed European Lung Cancer Congress held in Copenhagen. Host Dr. Stephen Liu, Dr. Heather Wakelee and Dr. Paul Van Schil discuss the important research presented at the meeting.
33 min
April 04, 2023 IASLC - EGFR Mutant NSCLC Post Osimertinib
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined by two thoracic medical oncologists who are both global experts in targeted therapy.
32 min
March 31, 2023 IASLC - LCC in Italian: Updates in Resectable NSCLC
IASLC - LCC in Italian: Updates in Resectable NSCLC by IASLC
53 min
March 24, 2023 IASLC - SCLC 2023 Meeting Preview
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a conversation about small cell lung cancer and previews the upcoming IASLC 2023 Hot Topic Meeting: Small Cell Lung Cancer in April which is focused on both preclinical and clinical advances in small cell lung cancer research. Joining the conversation are Alvaro Quintanal-Villalonga, PhD., from the Rudin Lab at Memorial Sloan Kettering Cancer Center in New York, and Kate Sutherland, PhD., from the Walter and Eliza Hall Institute of Medical Research in Australia.
25 min
March 21, 2023 IASLC The Great Debate Dr. Einhorn Dr. Simone And Dr. Florez
In this episode of Lung Cancer Considered, recorded at the 2023 Targeted Therapies of Lung Cancer meeting, host Dr. Narjust Florez moderates a conversation about the use of consolidated radiation in early-stage small cell lung cancer. Joining the debate are Dr. Lawrence Einhorn from the Indiana University School of Medicine and Dr. Charles Simone from Memorial Sloan Kettering.
18 min
March 09, 2023 LCC Targeted Therapy Recap
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a recap of the recent IASLC meeting, Targeted Therapies for Lung Cancer, or TTLC23 --a member-favorite, a relatively smaller meeting known for its fast pace and its breadth of content.
Guests include, the two co-chairs of the meeting:
Dr. Charu Aggarwal, thoracic medical oncologist at the Hospital of the University of Pennsylvania and the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at the University of Pennsylvania.
Dr. Joel Neal, thoracic medical oncologist and Associate Professor at Stanford University where he is also the Medical Director for the Cancer Clinical Trials Office.
39 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.